BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2026 8:10:54 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-11-17 03:49 |
|
Peer-Review Started |
|
2025-11-17 03:50 |
|
First Decision by Editorial Office Director |
|
2025-11-25 09:23 |
|
Return for Revision |
|
2025-11-25 09:23 |
|
Revised |
|
2025-12-04 11:37 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-09 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-09 06:50 |
|
Articles in Press |
|
2026-02-09 06:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-30 11:15 |
|
Publish the Manuscript Online |
|
2026-05-27 08:10 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Review |
| Article Title |
Current approaches to disease severity and therapy effectiveness assessment in patients with inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alexandre Loktionov |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alexandre Loktionov, Director, MD, PhD, -, DiagNodus Ltd, St John’s Innovation Centre, Cowley Road, Cambridge CB4 0WS, United Kingdom. alex.loktionov@diagnodus.com |
| Key Words |
Ulcerative colitis; Crohn’s disease; Endoscopy; Cross-section imaging; Biomarkers; Gut microbiome; Precision medicine; Multi-omics; Artificial intelligence |
| Core Tip |
Inflammatory bowel disease patients need continuous lifetime monitoring of disease activity and effects of therapeutic interventions. This review considers a wide range of approaches currently applied for this purpose. The reviewed modalities comprise clinical criteria, endoscopy, cross-sectional imaging, detection of biomarkers in body fluids and feces, gut microbiome analysis, and application of modern technologies, such as multi-omics and artificial intelligence. Artificial intelligence-driven integration of abundant information provided by a range of diagnostic and analytical approaches outlined in this review may help in transforming the current ‘one-size-fits-all’ inflammatory bowel disease treatment concept into a truly personalized model of disease care. |
| Publish Date |
2026-05-27 08:10 |
| Citation |
Loktionov A. Current approaches to disease severity and therapy effectiveness assessment in patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2026; 17(2): 116608 |
| URL |
https://www.wjgnet.com/2150-5349/full/v17/i2/116608.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v17.i2.116608 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
